These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 12905700

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues.
    Wada H, Matsumoto N, Maenaka K, Suzuki K, Yamamoto K.
    Eur J Immunol; 2004 Jan; 34(1):81-90. PubMed ID: 14971033
    [Abstract] [Full Text] [Related]

  • 3. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, Moretta A.
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [Abstract] [Full Text] [Related]

  • 4. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ.
    Nature; 1998 Feb 19; 391(6669):795-9. PubMed ID: 9486650
    [Abstract] [Full Text] [Related]

  • 5. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor.
    Borrego F, Masilamani M, Kabat J, Sanni TB, Coligan JE.
    Mol Immunol; 2005 Feb 19; 42(4):485-8. PubMed ID: 15607803
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ, Melero I, Navarro F, Carretero M, Bellón T, Llano M, Colonna M, Geraghty DE, López-Botet M.
    J Immunol; 1997 Jun 15; 158(12):5736-43. PubMed ID: 9190923
    [Abstract] [Full Text] [Related]

  • 8. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D, Sivori S, Accame L, Pareti L, Falco M, Geraghty D, Le Bouteiller P, Moretta L, Moretta A.
    Eur J Immunol; 1997 Aug 15; 27(8):1875-80. PubMed ID: 9295021
    [Abstract] [Full Text] [Related]

  • 9. Natural killer cell recognition of HLA class I molecules.
    Brooks AG, Boyington JC, Sun PD.
    Rev Immunogenet; 2000 Aug 15; 2(3):433-48. PubMed ID: 11256749
    [Abstract] [Full Text] [Related]

  • 10. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.
    Arlettaz L, Villard J, de Rham C, Degermann S, Chapuis B, Huard B, Roosnek E.
    Eur J Immunol; 2004 Dec 15; 34(12):3456-64. PubMed ID: 15517612
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor.
    Zingoni A, Palmieri G, Morrone S, Carretero M, Lopez-Botel M, Piccoli M, Frati L, Santoni A.
    Eur J Immunol; 2000 Feb 15; 30(2):644-51. PubMed ID: 10671222
    [Abstract] [Full Text] [Related]

  • 14. Differential expression of natural killer cell receptors (CD94/NKG2A) on T cells by the stimulation of G-CSF-mobilized peripheral blood mononuclear cells with anti-CD3 monoclonal antibody and cytokines: a study in stem cell donors.
    Tanaka J, Toubai T, Miura Y, Tsutsumi Y, Kato N, Umehara S, Toyoshima N, Ohta S, Asaka M, Imamura M.
    Transplant Proc; 2004 Oct 15; 36(8):2511-2. PubMed ID: 15561299
    [Abstract] [Full Text] [Related]

  • 15. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T, Jarousseau AC, Watier H, Boucraut J, Le Bouteiller P, Bardos P, Thibault G.
    J Immunol; 1999 May 15; 162(10):5902-9. PubMed ID: 10229826
    [Abstract] [Full Text] [Related]

  • 16. The role of TCR stimulation and TGF-beta in controlling the expression of CD94/NKG2A receptors on CD8 T cells.
    Gunturi A, Berg RE, Crossley E, Murray S, Forman J.
    Eur J Immunol; 2005 Mar 15; 35(3):766-75. PubMed ID: 15714583
    [Abstract] [Full Text] [Related]

  • 17. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
    Sivakumar PV, Gunturi A, Salcedo M, Schatzle JD, Lai WC, Kurepa Z, Pitcher L, Seaman MS, Lemonnier FA, Bennett M, Forman J, Kumar V.
    J Immunol; 1999 Jun 15; 162(12):6976-80. PubMed ID: 10358137
    [Abstract] [Full Text] [Related]

  • 18. Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells.
    Ding Y, Sumitran S, Holgersson J.
    Scand J Immunol; 1999 May 15; 49(5):459-65. PubMed ID: 10320637
    [Abstract] [Full Text] [Related]

  • 19. Signal sequences stop killer cells.
    Long EO.
    Nature; 1998 Feb 19; 391(6669):740-1, 743. PubMed ID: 9486638
    [No Abstract] [Full Text] [Related]

  • 20. Cytolytic activity against primary leukemic cells by inhibitory NK cell receptor (CD94/NKG2A)-expressing T cells expanded from various sources of blood mononuclear cells.
    Tanaka J, Iwao N, Toubai T, Tsutsumi Y, Miura Y, Kato N, Shigematsu A, Yamane M, Ota S, Kondo T, Kobayashi T, Takeda H, Kobayashi M, Asaka M, Imamura M.
    Leukemia; 2005 Mar 19; 19(3):486-9. PubMed ID: 15618959
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.